Elidel-Study: Elidel in Patients With Atopic Dermatitis

Atopic dermatitis is a common disease. Emollients and Elidel have both shown to be effective to treat this disease. The research question is, whether the effective component (Elidel) is better than the emollient to improve the skin function.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Atopic Dermatitis Congenital, Hereditary, and Neonatal Diseases and Abnormalities Dermatitis Dermatitis, Atopic Genetic Diseases, Inborn Hypersensitivity Hypersensitivity, Immediate Immune System Diseases Skin Diseases Skin Diseases, Eczematous Skin Diseases, Genetic Skin and Connective Tissue Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Technical University Dresden

Dresden, Saxony, 01307, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Age > 18 years
Atopic dermatitis on both lower arms at least 1% body surface area.
Atopic Dermatitis Severity Index (ADSI)-Score >= 6
Investigator Global Assessment (IGA)-Score >= 2

Exclusion criteria

Systemic therapy with immunosuppressive drugs within the past 24 weeks
Phototherapy against atopic dermatitis.
Antibiotic therapy against atopic dermatitis.
Allergy against Elidel.
Pregnancy
Nursing
Skin cancer

Treatment and study plan

Elidel-Creme

Drug

Sponsors and collaborators

Lead sponsor

Technische Universität Dresden

Other

Registry information

Official study title

Control of Therapy With Elidel vs Placebo in Patients With Atopic Dermatitis Using Bioengineering Methods

Important dates

Study start: 2005
Primary completion: 2007
Study completion: 2007
First posted: Sep 16, 2005
Registry last updated: May 9, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed